BD SiteRite(TM) 9 Ultrasound System - Clinical Study
Not yet recruiting
- Conditions
- BD SiteRite 9 for VAD Insertion
- Interventions
- Device: BD SiteRite(TM) 9
- First Posted Date
- 2024-10-09
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Becton, Dickinson and Company
- Target Recruit Count
- 149
- Registration Number
- NCT06632509
BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking Technology Clinical Study
Not yet recruiting
- Conditions
- BD Prevue II for Peripheral Intravenous Catheter Placement
- Interventions
- Device: BD Prevue(TM) II
- First Posted Date
- 2024-10-09
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Becton, Dickinson and Company
- Target Recruit Count
- 149
- Registration Number
- NCT06632496
Investigational Study With the BD PosiFlushâ„¢ SafeScrub on NADs
Not Applicable
Recruiting
- Conditions
- CRBSI - Catheter Related Bloodstream Infection
- Interventions
- Device: BD PosiFlushâ„¢ SafeScrubDevice: BD PosiFlushâ„¢
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Becton, Dickinson and Company
- Target Recruit Count
- 220
- Registration Number
- NCT06604026
- Locations
- 🇦🇹
Medical University Vienna, Vienna, Austria
Clinical Validation of BACTECâ„¢ Plus Aerobic/F Culture Vials Compared With Equivalent Product
Recruiting
- Conditions
- Sepsis
- Interventions
- Diagnostic Test: test Aerobic/F Culture VialsDiagnostic Test: control Aerobic/F Culture Vials
- First Posted Date
- 2024-05-23
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Becton, Dickinson and Company
- Target Recruit Count
- 1000
- Registration Number
- NCT06426121
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
BD Evolveâ„¢ On-body Injector's Adherence Performance - Wear Study
Not Applicable
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Device: Device wear on skin
- First Posted Date
- 2024-02-08
- Last Posted Date
- 2024-03-08
- Lead Sponsor
- Becton, Dickinson and Company
- Target Recruit Count
- 128
- Registration Number
- NCT06247644
- Locations
- 🇺🇸
TKL, Fair Lawn, New Jersey, United States
Prospective Clinical Evaluation of BD NRFitâ„¢ Devices and Accessories.
Completed
- Conditions
- AnesthesiaAnalgesia
- Interventions
- Device: BD NRFitâ„¢ Spinal Needles, BD NRFitâ„¢ Spinal Introducer Needles, and BD NRFitâ„¢ Syringes
- First Posted Date
- 2023-07-20
- Last Posted Date
- 2024-07-09
- Lead Sponsor
- Becton, Dickinson and Company
- Target Recruit Count
- 161
- Registration Number
- NCT05953363
- Locations
- 🇩🇪
Universitätsklinikum Leipzig, Leipzig, Germany
🇦🇹Medizinische Universität Wien, Wien, Austria
🇦🇹Barmherzige Bruder Krankenhaus Salzburg, Salzburg, Austria
Study of BD Pre-filled Flush Syringes in China
Not Applicable
Completed
- Conditions
- Effectiveness and Safety of Pre-filled Flush Syringe
- Interventions
- Device: Intravenous Access Device Flushing
- First Posted Date
- 2023-03-10
- Last Posted Date
- 2024-07-30
- Lead Sponsor
- Becton, Dickinson and Company
- Target Recruit Count
- 378
- Registration Number
- NCT05763147
- Locations
- 🇨🇳
Beijing Hospital, Beijing, China
🇨🇳Beijing Friendship Hospital, Beijing, China
🇨🇳Beijing Jishuitan Hospital, Beijing, China
BD OneFlow CLPD Panel (BD OneFlow LST, and B-CLPD T1 to T4 Assays) on the BD FACSLyric System.
Completed
- Conditions
- Chronic Lymphoproliferative Diseases (CLPD)
- First Posted Date
- 2022-09-28
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Becton, Dickinson and Company
- Target Recruit Count
- 322
- Registration Number
- NCT05557422
- Locations
- 🇳🇱
Erasmus Medical Center, Laboratory Medical Immunology, Department of Immunology, Rotterdam, Netherlands
🇺🇸University of Norht Calolina, Chapel Hill, North Carolina, United States
🇺🇸CorePATH Laboratories, San Antonio, Texas, United States
Investigational On-body Injector Clinical Study
Not Applicable
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Device: In-clinic wear firstDevice: Home wear first
- First Posted Date
- 2022-09-23
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- Becton, Dickinson and Company
- Target Recruit Count
- 70
- Registration Number
- NCT05553418
- Locations
- 🇫🇷
Eurofins Optimed, Gières, France
BD Veritorâ„¢ At-Home and BD Veritorâ„¢ Professional
Completed
- Conditions
- Upper Respiratory Infection
- Interventions
- Diagnostic Test: BD Veritor At-HomeDiagnostic Test: BD Veritor Professional
- First Posted Date
- 2022-04-29
- Last Posted Date
- 2023-06-07
- Lead Sponsor
- Becton, Dickinson and Company
- Target Recruit Count
- 1146
- Registration Number
- NCT05352581
- Locations
- 🇳🇿
Southern Clinical Trials - Tasman, Nelson, New Zealand
🇳🇿Southern Clinical Trials - Totara, Auckland, New Zealand
🇳🇿Lakeland Clinical Trials - Waikato, Hamilton, New Zealand
© Copyright 2025. All Rights Reserved by MedPath